Antifungal prophylaxis in hematopoietic stem cell transplant recipients

Research output: Contribution to journalArticle

Abstract

Infections remain a major complication of hematopoietic stem cell transplantation, with recent trends indicating that fungal pathogens have become one of the most common causes of death. Attention has turned to the use of prophylactic antifungal medications to prevent infection with both Candida and Aspergillus species. Recent studies, which are reviewed within, indicate success in preventing infections caused by azole-susceptible Candida species, accompanied by improved transplant-related mortality rates in high-risk patients. Further studies are necessary to develop strategies to prevent infection with Aspergillus species.

Original languageEnglish (US)
Pages (from-to)423-426
Number of pages4
JournalCurrent Opinion in Infectious Diseases
Volume14
Issue number4
StatePublished - 2001
Externally publishedYes

Fingerprint

Hematopoietic Stem Cells
Transplants
Aspergillus
Infection
Candida
Azoles
Hematopoietic Stem Cell Transplantation
Cause of Death
Mortality
Transplant Recipients

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Antifungal prophylaxis in hematopoietic stem cell transplant recipients. / Marr, Kieren.

In: Current Opinion in Infectious Diseases, Vol. 14, No. 4, 2001, p. 423-426.

Research output: Contribution to journalArticle

@article{f5a39036da28481ea40a060d4844e977,
title = "Antifungal prophylaxis in hematopoietic stem cell transplant recipients",
abstract = "Infections remain a major complication of hematopoietic stem cell transplantation, with recent trends indicating that fungal pathogens have become one of the most common causes of death. Attention has turned to the use of prophylactic antifungal medications to prevent infection with both Candida and Aspergillus species. Recent studies, which are reviewed within, indicate success in preventing infections caused by azole-susceptible Candida species, accompanied by improved transplant-related mortality rates in high-risk patients. Further studies are necessary to develop strategies to prevent infection with Aspergillus species.",
author = "Kieren Marr",
year = "2001",
language = "English (US)",
volume = "14",
pages = "423--426",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Antifungal prophylaxis in hematopoietic stem cell transplant recipients

AU - Marr, Kieren

PY - 2001

Y1 - 2001

N2 - Infections remain a major complication of hematopoietic stem cell transplantation, with recent trends indicating that fungal pathogens have become one of the most common causes of death. Attention has turned to the use of prophylactic antifungal medications to prevent infection with both Candida and Aspergillus species. Recent studies, which are reviewed within, indicate success in preventing infections caused by azole-susceptible Candida species, accompanied by improved transplant-related mortality rates in high-risk patients. Further studies are necessary to develop strategies to prevent infection with Aspergillus species.

AB - Infections remain a major complication of hematopoietic stem cell transplantation, with recent trends indicating that fungal pathogens have become one of the most common causes of death. Attention has turned to the use of prophylactic antifungal medications to prevent infection with both Candida and Aspergillus species. Recent studies, which are reviewed within, indicate success in preventing infections caused by azole-susceptible Candida species, accompanied by improved transplant-related mortality rates in high-risk patients. Further studies are necessary to develop strategies to prevent infection with Aspergillus species.

UR - http://www.scopus.com/inward/record.url?scp=0034919316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034919316&partnerID=8YFLogxK

M3 - Article

C2 - 11964859

AN - SCOPUS:0034919316

VL - 14

SP - 423

EP - 426

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 4

ER -